To include your compound in the COVID-19 Resource Center, submit it here.

UC undeterred by CRISPR patent ruling

A University of California group is optimistic that its CRISPR IP rights will cover use of the technology in all cell types, despite a U.S. patent board's ruling Wednesday that an opposing group's IP is patentable separately. The ruling, issued by the U.S. Patent Trial and Appeals board, terminated an interference proceeding which could have

Read the full 554 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers